Clinical Trial Update: A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial comparing zoledronic acid to an oral bisphosphonate for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Oral bisphosphonate (unspecified)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED